Panel Discussion: A 101 in Expedited Programs for Gene Therapy
Time: 2:00 pm
day: Regulatory - PM
Details:
- Outlining the practicalities of gaining FDA expedited designations
- Criteria for designation and best practices with regulatory touchpoints
- Considerations for successful interactions with CBER reviewers
- Common reasons for denial of RMAT applications